EMA Biennial Report 2016/2017: Joint CVMP/CHMP Working group on the Application of the 3Rs in Regulatory Testing of Medical Products

This report is aimed at informing pharmaceutical companies and the public of the EMA activities in relation to “3Rs” (replacement, reduction, refinement) during 2016 and 2017. The report summarises the recommendations developed and the organisational structure enabling the development of such guidance. It also looks into the future with details about a new mandate to…

Read More

SSFAoggi meets Dr. Honorio Silva, IFAPP President

    SSFA was one of the 12 founding members of IFAPP, the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine. Indeed, it was during a Conference held in Florence in September 1975 that IFAPP was officially launched, as the first name of the federation was IFAMAPI (International Federation of Associations of Medical…

Read More

FDA improves access to reports of adverse drug reactions

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The Agency also is responsible for the safety and security of our nation’s food supply,…

Read More